J Cardiovasc Imaging.  2018 Sep;26(3):147-154. 10.4250/jcvi.2018.26.e12.

Sequential Changes in Left Ventricular Systolic Myocardial Deformation Mechanics in Children with Recurrent Kawasaki Disease

• Kang SJ
• Jin BK
• Hwang SJ
• Kim HJ

• KMID: 2429856
• DOI: http://doi.org/10.4250/jcvi.2018.26.e12

Abstract

BACKGROUND
Sequential changes in left ventricular (LV) systolic function over time in patients with recurrent episodes of Kawasaki disease (KD) remain unclear.
METHODS
Twenty-five children with recurrent KD were retrospectively studied. Using conventional echocardiographic parameters and myocardial deformation analysis, systolic LV function in children in initial and recurrent KD episodes were compared with separate control groups, comprising 15 controls each. Recurrent KD was defined as occurring at an interval of ≥2 months between the initial and recurrent episodes.
RESULTS
The interval range between initial and recurrent episodes of KD was 3-103 months. In children with KD, 8 (32%) were <1 year of age at the initial episode, 10 (40%) had a recurrence within 1 year of the initial episode, and 4 (16%) and 5 (20%) were intravenous immune globulin nonresponders in initial and recurrent episodes, respectively. In both the initial and recurrent episodes of KD, the mean LV longitudinal peak systolic ε was all within normal range. However, when compared to controls, mean LV longitudinal peak systolic ε was decreased in patients with KD in the acute phases of both the initial and recurrent episodes. When compared to controls, mean LV longitudinal peak systolic ε was decreased in patients with KD in the convalescent phase of the recurrent episodes.
CONCLUSIONS
Subclinical decreases in myocardial systolic deformation, as evidenced by decreased LV longitudinal peak systolic ε, may persist in children in the convalescent phase of recurrent KD; further studies involving larger numbers of patients may be needed for verification.

Keyword

Kawasaki disease; Recurrent; Left ventricle; Deformation

MeSH Terms

Child*
Echocardiography
Heart Ventricles
Humans
Immunoglobulins, Intravenous
Mechanics*
Mucocutaneous Lymph Node Syndrome*
Recurrence
Reference Values
Retrospective Studies
Immunoglobulins, Intravenous

Reference

1. Sudo D, Nakamura Y. Nationwide surveys show that the incidence of recurrent Kawasaki disease in Japan has hardly changed over the last 30 years. Acta Paediatr. 2017; 106:796–800.

2. Moran AM, Newburger JW, Sanders SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J. 2000; 139:217–223.

3. Newburger JW, Sanders SP, Burns JC, Parness IA, Beiser AS, Colan SD. Left ventricular contractility and function in Kawasaki syndrome. Effect of intravenous gamma-globulin. Circulation. 1989; 79:1237–1246.

4. Maddox RA, Holman RC, Uehara R, et al. Recurrent Kawasaki disease: USA and Japan. Pediatr Int. 2015; 57:1116–1120.

5. Chahal N, Somji Z, Manlhiot C, et al. Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada. Pediatr Int. 2012; 54:383–387.

6. Haque U, Stiver C, Rivera BK, et al. Right ventricular performance using myocardial deformation imaging in infants with bronchopulmonary dysplasia. J Perinatol. 2017; 37:81–87.

7. Yu JJ, Choi HS, Kim YB, et al. Analyses of left ventricular myocardial deformation by speckle-tracking imaging during the acute phase of Kawasaki disease. Pediatr Cardiol. 2010; 31:807–812.

8. McCandless RT, Minich LL, Wilkinson SE, McFadden ML, Tani LY, Menon SC. Myocardial strain and strain rate in Kawasaki disease. Eur Heart J Cardiovasc Imaging. 2013; 14:1061–1068.

9. Kang SJ, Kwon YW, Hwang SJ, Kim HJ, Jin BK, Yon DK. Clinical utility of left atrial strain in children in the acute phase of Kawasaki disease. J Am Soc Echocardiogr. 2018; 31:323–332.

10. Pirat B, Khoury DS, Hartley CJ, et al. A novel feature-tracking echocardiographic method for the quantitation of regional myocardial function: validation in an animal model of ischemia-reperfusion. J Am Coll Cardiol. 2008; 51:651–659.

11. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114:1708–1733.

12. Hirata S, Nakamura Y, Yanagawa H. Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan. Acta Paediatr. 2001; 90:40–44.

13. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005; 18:1440–1463.

14. McCrindle BW, Li JS, Minich LL, et al. Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation. 2007; 116:174–179.

15. Voigt JU, Pedrizzetti G, Lysyansky P, et al. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging. J Am Soc Echocardiogr. 2015; 28:183–193.

16. Kutty S, Padiyath A, Li L, et al. Functional maturation of left and right atrial systolic and diastolic performance in infants, children, and adolescents. J Am Soc Echocardiogr. 2013; 26:398–409.e2.

17. Yang HM, Du ZD, Fu PP. Clinical features of recurrent Kawasaki disease and its risk factors. Eur J Pediatr. 2013; 172:1641–1647.

18. Dogan V, Öcal B, Orun UA, et al. Strain and strain rate echocardiography findings in children with asymptomatic congenital aortic stenosis. Pediatr Cardiol. 2013; 34:1152–1158.

19. Perk G, Tunick PA, Kronzon I. Non-Doppler two-dimensional strain imaging by echocardiography--from technical considerations to clinical applications. J Am Soc Echocardiogr. 2007; 20:234–243.

20. Dandel M, Hetzer R. Echocardiographic strain and strain rate imaging--clinical applications. Int J Cardiol. 2009; 132:11–24.

21. Kao CH, Hsieh KS, Wang YL, Wang SJ, Yeh SH. The detection of ventricular dysfunction and carditis in children with Kawasaki disease using equilibrium multigated blood pooling ventriculography and 99Tcm-HMPAO-labelled WBC heart scans. Nucl Med Commun. 1993; 14:539–543.

22. Kang SJ, Ha J, Hwang SJ, Kim HJ. Long term outcomes of left atrial reservoir function in children with a history of Kawasaki disease. J Cardiovasc Ultrasound. 2018; 26:26–32.

23. Printz BF, Sleeper LA, Newburger JW, et al. Noncoronary cardiac abnormalities are associated with coronary artery dilation and with laboratory inflammatory markers in acute Kawasaki disease. J Am Coll Cardiol. 2011; 57:86–92.

24. Phadke D, Patel SS, Dominguez SR, et al. Tissue Doppler imaging as a predictor of immunoglobulin resistance in Kawasaki disease. Pediatr Cardiol. 2015; 36:1618–1623.